Memecoins Surge: Dogecoin, Shiba Inu, Floki Lead Gainsby John Darbie 25.06.2024Memecoins like Floki, Dogwifhat, and Bonk defy market downturn with double-digit gains, highlighting their resilience amid broader crypto sell-offs.
LockBit Claims Massive Breach of Federal Reserve: 33TB Databy Lilu Anderson 25.06.2024"LockBit claims a massive 33TB data breach of the U.S. Federal Reserve, casting doubts as cybersecurity experts question the credibility ...
Bitcoin’s Supply in Profit Drops Amid Post-Halving Effectsby John Darbie 25.06.2024Bitcoin’s supply in profit drops to 80% post-halving, reflecting market changes. Key historical data and recent trends offer vital investment ...
Bitcoin Prices Tumble Below $60,000 Amid Mt Gox Fearsby John Darbie 25.06.2024Bitcoin dips below $60K due to profit-taking, miner selling, and Mt. Gox repayment fears, with experts debating the long-term impact.
Enerpac Slides 9% on Q3 Revenue Miss – Strong Balance Sheetby Mark Eisenberg 25.06.2024Enerpac shares dropped 9% after a Q3 revenue miss despite EPS meeting expectations and improvements in gross margin and EBITDA.
Brazil Stocks Climb: Bovespa Index Gains 1.07%by Mark Eisenberg 25.06.2024"Brazil Stocks Rally with Bovespa Up 1.07%; Top Gainers Include Magazine Luiza, MRV Engenharia. Market Stability Evident as Volatility Drops."
Hedge Funds Exit Bitcoin & Short MicroStrategy: Insightsby John Darbie 25.06.2024Peter Schiff warns hedge funds are selling Bitcoin and shorting MicroStrategy, signaling a shift in strategy that could impact market ...
MetalCore Launches Ethereum Token Ahead of Latest Betaby John Darbie 25.06.2024Studio369 launches Ethereum token with MetalCore's Closed Beta 3, introducing new gameplay modes, economic features, and NFT in-game assets.
Binance CEO: Bitcoin to Surpass $80K by 2025; Solana & BNB to Riseby John Darbie 25.06.2024Binance CEO predicts Bitcoin will hit $80K by 2025, sparking interest in altcoins like Solana, Rollblock, and Binance Coin as ...
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Sharesby Mark Eisenberg 25.06.2024CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.